|
1
|
Babjuk M, Böhle A, Burger M, Capoun O,
Cohen D, Compérat EM, Hernández V, Kaasinen E, Palou J, Rouprêt M,
et al: EAU guidelines on non-muscle-invasive urothelial carcinoma
of the bladder: Update 2016. Eur Urol. 71:447–461. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Witjes Alfred J, Lebret T, Compérat EM,
Cowan NC, De Santis M, Bruins HM, Hernández V, Espinós EL, Dunn J,
Rouanne M, et al: Updated 2016 EAU guidelines on muscle-invasive
and metastatic bladder cancer. Eur Urol. 71:462–475. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Knowles MA and Hurst CD: Molecular biology
of bladder cancer: New insights into pathogenesis and clinical
diversity. Nat Rev Cancer. 15:25–41. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sjödahl G, Lauss M, Lövgren K, Chebil G,
Gudjonsson S, Veerla S, Patschan O, Aine M, Fernö M, Ringnér M, et
al: A molecular taxonomy for urothelial carcinoma. Clin Cancer Res.
18:3377–3386. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang G, Lu X and Yuan L: LncRNA: A link
between RNA and cancer. Biochim Biophys Acta. 1839:1097–1109. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang Q, Su M, Lu G and Wang J: The
complexity of bladder cancer: Long noncoding RNAs are on the stage.
Mol Cancer. 12:1012013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang XS, Zhang Z, Wang HC, Cai JL, Xu QW,
Li MQ, Chen YC, Qian XP, Lu TJ, Yu LZ, et al: Rapid identification
of UCA1 as a very sensitive and specific unique marker for human
bladder carcinoma. Clin Cancer Res. 12:4851–4858. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Milowich D, Le Mercier M, De Neve N,
Sandras F, Roumeguere T, Decaestecker C, Salmon I and Rorive S:
Diagnostic value of the UCA1 test for bladder cancer
detection: A clinical study. Springerplus. 4:3492015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Srivastava AK, Singh PK, Rath SK, Dalela
D, Goel MM and Bhatt ML: Appraisal of diagnostic ability of UCA1 as
a biomarker of carcinoma of the urinary bladder. Tumour Biol.
35:11435–11442. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xue M, Li X, Li Z and Chen W: Urothelial
carcinoma associated 1 is a hypoxia-inducible factor-1α-targeted
long noncoding RNA that enhances hypoxic bladder cancer cell
proliferation, migration, and invasion. Tumour Biol. 35:6901–6912.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang X, Gong Y, Jin B, Wu C, Yang J, Wang
L, Zhang Z and Mao Z: Long non-coding RNA urothelial carcinoma
associated 1 induces cell replication by inhibiting BRG1 in 5637
cells. Oncol Rep. 32:1281–1290. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang C, Li X, Wang Y, Zhao L and Chen W:
Long non-coding RNA UCA1 regulated cell cycle distribution via CREB
through PI3-K dependent pathway in bladder carcinoma cells. Gene.
496:8–16. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu FT, Zhu PQ, Luo HL, Zhang Y and Qiu C:
Prognostic value of long non-coding RNA UCA1 in human solid tumors.
Oncotarget. 7:57991–58000. 2016.PubMed/NCBI
|
|
14
|
Wang X, Peng F, Cheng L, Yang G, Zhang D,
Liu J, Chen X and Zhao S: Prognostic and clinicopathological role
of long non-coding RNA UCA1 in various carcinomas. Oncotarget.
8:28373–28384. 2017.PubMed/NCBI
|
|
15
|
Droop J, Szarvas T, Schulz WA, Niedworok
C, Niegisch G, Scheckenbach K and Hoffmann MJ: Diagnostic and
prognostic value of long noncoding RNAs as biomarkers in urothelial
carcinoma. PLoS One. 12:e01762872017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ding W, Gou Y, Sun C, Xia G, Wang H, Chen
Z, Tan J, Xu K and Qiang D: Ki-67 is an independent indicator in
non-muscle invasive bladder cancer (NMIBC); combination of EORTC
risk scores and Ki-67 expression could improve the risk
stratification of NMIBC. Urol Oncol. 32(42): e13–e19. 2014.
|
|
17
|
Margulis V, Shariat SF, Ashfaq R,
Sagalowsky AI and Lotan Y: Ki-67 is an independent predictor of
bladder cancer outcome in patients treated with radical cystectomy
for organ-confined disease. Clin Cancer Res. 12:7369–7373. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Moch H, Humphrey PA, Ulbright TM and
Reuter VE: WHO Classification of Tumours of the Urinary System and
Male Genital Organs. 4th edition. IARC; Lyon 8: 2016
|
|
19
|
Brierley JD, Gospodarowicz MK and
Wittekind C: The TNM Classification of Malignant Tumours. 8th
edition. Union for International Cancer Control (UICC);
Wiley-Blackwell: 2017
|
|
20
|
Decaestecker C, Lopez XM, D'Haene N,
Roland I, Guendouz S, Duponchelle C, Berton A, Debeir O and Salmon
I: Requirements for the valid quantification of immunostains on
tissue microarray materials using image analysis. Proteomics.
9:4478–4494. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rorive S, Lopez XM, Maris C, Trepant AL,
Sauvage S, Sadeghi N, Roland I, Decaestecker C and Salmon I: TIMP-4
and CD63: New prognostic biomarkers in human astrocytomas. Mod
Pathol. 23:1418–1428. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Talhouk A, McConechy MK, Leung S, Li-Chang
HH, Kwon JS, Melnyk N, Yang W, Senz J, Boyd N, Karnezis AN, et al:
A clinically applicable molecular-based classification for
endometrial cancers. Br J Cancer. 113:299–310. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kurman RJ, Carcangiu ML, Herrington CS and
Young RH: WHO classification of tumors of female reproductive
organs. 4th edition. IARC; Lyon 6: 2014
|
|
24
|
Mota A, Triviño JC, Rojo-Sebastian A,
Martínez-Ramírez A, Chiva L, González-Martín A, Garcia JF,
Garcia-Sanz P and Moreno-Bueno G: Intra-tumor heterogeneity in TP53
null high grade serous ovarian carcinoma progression. BMC Cancer.
15:9402015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Martens-Uzunova ES, Böttcher R, Croce CM,
Jenster G, Visakorpi T and Calin GA: Long noncoding RNA in
prostate, bladder, and kidney cancer. Eur Urol. 65:1140–1151. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xue M, Chen W and Li X: Urothelial cancer
associated 1: A long noncoding RNA with a crucial role in cancer. J
Cancer Res Clin Oncol. 142:1407–1419. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guhley ML and Tang W: Laboratory assays
for Epstein-Barr virus-related disease. J Mol Diagn. 10:279–292.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Aine M, Eriksson P, Liedberg F, Höglund M
and Sjödahl G: On molecular classification of bladder cancer: Out
of one, many. Eur Urol. 68:921–923. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim PH, Cha EK, Sfakianos JP, Iyer G,
Zabor EC, Scott SN, Ostrovnaya I, Ramirez R, Sun A, Shah R, et al:
Genomic predictors of survival in patients with high-grade
urothelial carcinoma of the bladder. Eur Urol. 67:198–201. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kumar PP, Emechebe U, Smith R, Franklin S,
Moore B, Yandell M, Lessnick SL and Moon AM: Coordinated control of
senescence by lncRNA and a novel T-box3 co-repressor complex.
Elife. 3:2014. View Article : Google Scholar : PubMed/NCBI
|
